Stock Market & Financial Investment News

News Breaks January 2, 2013 10:44 EDT DVA DaVita retreats after fiscal cliff deal cuts dialysis payments Dialysis service provider DaVita (DVA) is falling after the fiscal cliff deal passed by Congress reportedly included a provision that will reduce the payments that diaiysis providers will receive from the Centers for Medicare & Medicaid Services, or CMS. The legislation, which lowers payments to dialysis providers beginning in 2014, will reduce CMS' payments for dialysis by about 2.8% in that year, Citigroup analyst Gary Taylor estimated in a note to investors yesterday. A 2.8% cut would reduce DaVita's EPS by 73c in 2014, Talyor believes. Taylor had expected CMS' payments to drop 2% next year. Moreover, the legislation will prevent CMS from paying for oral advanced kidney disease treatments until at least 2016, Taylor added. Some investors had hoped that DaVita's profits from oral drugs would offset any reductions in payments, added the analyst, who maintained a Neutral rating on the stock. In mid-morning trading, DaVita dropped $2.12, or 1.92%, to $108.41. News For DVA From The Last 14 Days Check below for free stories on DVA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 15, 2013 16:55 EDT DVA Berkshire Hathaway gives quarterly update on stakes Subscribe for More Information May 8, 2013 16:48 EDT DVA Rockwell Medical announces long-term supply agreement with DaVita Subscribe for More Information 16:15 EDT DVA Rockwell Medical signs long-term supply agreement with DaVita "Going forward we expect to see increased sales growth, notably from our CitraPure product line, new product offerings and from the increased commitment in our new supply contract with DaVita," the company said. May 7, 2013 16:50 EDT DVA Berkshire Hathaway in agreement to not take stake larger than 25% in DaVita Subscribe for More Information 16:19 EDT DVA DaVita narrows FY13 operating income view to 1.8B-$1.9B from $1.75B-$1.9B Subscribe for More Information 16:17 EDT DVA DaVita reports Q1 adjusted EPS $1.84, consensus $1.79 Reports Q1 revenue $2.83B, consensus $2.78B. Sign up for a free trial to see the rest of the stories you've been missing.